Senate Commerce Committee Statement to Senate, No. 2886 — State of New Jersey (February 10, 2025)
Summary
A Senate Commerce Committee statement to the Senate on Senate Bill No. 2886, State of New Jersey, dated February 10, 2025, reporting the bill favorably with committee amendments. As amended, the bill requires a pharmacy practice site to display a notice on its website about insulin manufacturer assistance programs, with the details drafted by the Department of Health. A pharmacy must also provide, on an individual's request, a pamphlet created by the department about those programs, and insulin manufacturers may ask to be included in the notices and pamphlets. The bill takes effect twelve months from the date it is signed into law.
Summary drafted by a model from the document's text below and checked by script against that text before publication. It is a navigation aid, not a reading of what the document proves. Where AI is used
Cite this document
“Senate Commerce Committee Statement to Senate, No. 2886 — State of New Jersey (February 10, 2025).”
Archived at Pandemic Darlings, https://pandemicdarlings.com/source-documents/s2886-scm-statement-2-10-2025-91f437eac7/
, SHA-256 a365b98675d8fb9d8600f005cdbce58312aa7c1a6b12039e5e56bed74c61ae34.Full text
SENATE COMMERCE COMMITTEE STATEMENT TO SENATE, No. 2886 with committee amendments STATE OF NEW JERSEY DATED: FEBRUARY 10, 2025 The Senate Commerce Committee reports favorably and with committee amendments Senate Bill No. 2886. This bill requires pharmacies to provide certain information regarding insulin manufacturer assistance programs. As amended, under this bill, a pharmacy practice site will be required to display, in a conspicuous manner, a notice on its website, concerning insulin manufacturer assistance programs at all points of sale, the details of which are to be drafted by the Department of Health. A pharmacy practice site is also required to provide, upon the request of an individual, a pamphlet created by the department concerning insulin manufacturer assistance programs. Insulin manufacturers offering an assistance program may inform the department of their intention to be included in the notices and pamphlets. The effective date of the bill is twelve months from the date it is signed into law. COMMITTEE AMENDMENTS : The committee amended the bill to: (1) require a pharmacy to display, in a conspicuous manner, information about insulin assistance programs on the website of the pharmacy and have the Department of Health draft the information to include on the website; (2) make the distribution of pamphlets on insulin assistance programs by request of an individual to the pharmacy; and (3) alter the effective date to twelve months from the date it is signed.
File and source
- File
- 2025-02-10_SCM_S2886_S1.htm
- Size
- 6,784 bytes
- SHA-256
- a365b98675d8fb9d8600f005cdbce58312aa7c1a6b12039e5e56bed74c61ae34
- Our copy
- 2025-02-10_SCM_S2886_S1.htm
- Original
- No public link identified.